ARA290

ARA-290 is a synthetic peptide derived from erythropoietin (EPO) that has been specifically engineered to retain tissue-protective and anti-inflammatory properties without stimulating red blood cell production. Because of this modification, ARA-290 is often referred to as a non-erythropoietic EPO-derived peptide.

What ARA-290 Is

• Peptide type: Synthetic EPO-derived peptide

• Length: 11 amino acids

• Alternative name: Cibinetide (used in clinical research settings)

• Classification: Tissue-protective peptide

• Regulatory status: Investigational / research use (not an approved medication)

Key Purpose & Research Focus

ARA-290 has been studied primarily for its role in:

• Reducing inflammation

• Protecting nerves and tissues

• Supporting cellular repair mechanisms

• Modulating immune and inflammatory responses

Unlike erythropoietin, ARA-290 does not increase hematocrit or red blood cell count, which significantly improves its safety profile in research applications.